Assets Pharmaceutical Portfolio Management 
Trade Brains
JULY 16, 2025
Aarti Pharmalabs Limited Aarti Pharmalabs Limited was established in 2022 following a demerger from Aarti Industries and is engaged in manufacturing active pharmaceutical ingredients (APIs), intermediates, and specialty chemicals, serving global pharmaceutical, biotechnology, and healthcare companies with integrated research-driven solutions.
Trade Brains
JUNE 18, 2025
Even in 2025, many of the world’s richest people are portfolio managers, stock traders, or financial firm founders. Its attractions include asset appreciation, leverage, and repeat income in the form of rents. Healthcare & Pharmaceuticals Though never in the limelight, healthcare is a lucrative and essential industry.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Carson Wealth
APRIL 4, 2025
Then we also have tariffs on autos, steel and aluminum, and upcoming tariffs on things like lumber and pharmaceuticals. Theres also the problem of stranded assets for US companies. It also has implications for flows of capital into various global assets, which could impact differential returns between all these assets.
The Big Picture
APRIL 8, 2025
She was CIO at Merrill Lynch Asset Management, and now CIO at both Morgan Stanley Wealth Management and runs their asset allocation models and their outsourced chief investment officer models. ’cause the asset management business of Sanford Bernstein, as everyone I think knows, was a deep value shop.
The Big Picture
MAY 20, 2025
First of all, my, some of my co-portfolio managers will bristle if you refer to us as a factor based firm. Tell us a little bit about the impact of that on running an asset management business. How do you manage around that 00:38:22 [Speaker Changed] As a disciplined investment shop? Research and development.
Brown Advisory
SEPTEMBER 20, 2017
Conversation with the Portfolio Manager: Mid-Cap Growth Strategy achen Wed, 09/20/2017 - 16:43 Over time, the Brown Advisory small-cap growth team, led by Christopher Berrier and George Sakellaris, watched numerous successful investments compound and grow out of their investible universe. That’s attractive in and of itself.
Brown Advisory
SEPTEMBER 20, 2017
Conversation with the Portfolio Manager: Mid-Cap Growth Strategy. While this was frustrating at times, it produced a valuable asset – a sizeable library of fully vetted “up cap” growth ideas. While both mid-cap portfolio managers believe their experience gives them an advantage, other factors set them apart as well.
Expert insights. Personalized for you.
Let's personalize your content